| ²é¿´: 4294 | »Ø¸´: 5 | ||
ÐÜÎÀÑÞгæ (³õÈëÎÄ̳)
|
[ÇóÖú]
international immunopharmacology ÒÑÓÐ2È˲ÎÓë
|
| ÇëÎÊͶinternational immunopharmacologyÐèÒª¸å·ÑÂ𣿠|
» ²ÂÄãϲ»¶
085701Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
321Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
26¿¼Ñе÷¼Á0710 0860
ÒѾÓÐ12È˻ظ´
270»¯¹¤Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸0817»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Çóµ÷¼Á
ÒѾÓÐ23È˻ظ´
309Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ£¬³õÊԳɼ¨350Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
081700»¯Ñ§¹¤³ÌÓë¼¼Êõ Ò»Ö¾Ô¸Öк£Ñó 323 Çóµ÷¼ÁѧУ
ÒѾÓÐ13È˻ظ´
Çóµ÷¼Á£º085600²ÄÁÏÓ뻯¹¤£¬¿¼²Ä¿Æ»ù£¬×Ü·Ö319
ÒѾÓÐ24È˻ظ´
ÍÁľ304Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖú£¬ÕâÑù˵ÎÄÕÂÄܲ»Äܱ»½ÓÊÜ£¿
ÒѾÓÐ9È˻ظ´
ʳƷ´ÖÌáÎïÊ×´Î×öÁ˺ܶàÒ©Àí¹¤×÷£¬Ó¦¸Ã·¢Ê²Ã´SCIÔÓÖ¾£¿
ÒѾÓÐ3È˻ظ´
ͶʲôÆÚ¿¯ÄØ£¿Éó¸å¿ìµÄ
ÒѾÓÐ27È˻ظ´
¼±¼±¼±-----Ó¢ÎÄÂÛÎÄ·¢±í£¬Çó°ïÖú£¡
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿Ç󼏯ªÎÄÏ×µÄÌâÄ¿
ÒѾÓÐ9È˻ظ´
397905819
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 411.5
- ºì»¨: 1
- Ìû×Ó: 122
- ÔÚÏß: 4.6Сʱ
- ³æºÅ: 762266
- ×¢²á: 2009-05-03
- רҵ: Ò©¼Áѧ
2Â¥2014-03-31 11:32:19
ÐÜÎÀÑÞ
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 43.5
- ºì»¨: 1
- Ìû×Ó: 3
- ÔÚÏß: 2.2Сʱ
- ³æºÅ: 2172025
- ×¢²á: 2012-12-07
- רҵ: Ò©¼Áѧ
3Â¥2014-03-31 14:23:26
397905819
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 411.5
- ºì»¨: 1
- Ìû×Ó: 122
- ÔÚÏß: 4.6Сʱ
- ³æºÅ: 762266
- ×¢²á: 2009-05-03
- רҵ: Ò©¼Áѧ
4Â¥2014-04-09 07:44:50
ÄÖÄÖС±¦
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 4.8
- Ìû×Ó: 14
- ÔÚÏß: 5.8Сʱ
- ³æºÅ: 3097289
- ×¢²á: 2014-03-28
- רҵ: Ò©Îﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
ÒÔÏÂÊÇÆäguide for authorÉϵÄÔ»° Open Access • Articles are freely available to both subscribers and the wider public with permitted reuse • An Open Access publication fee is payable by authors or their research funder Subscription • Articles are made available to subscribers as well as developing countries and patient groups through our access programs (http://www.elsevier.com/access) • No Open Access publication fee ²»ÔÚÏß·¢±íµÄ»°Ó¦¸ÃûÓаæÃæ·Ñ°É |
5Â¥2014-06-05 21:37:13
zhouchengyan
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 44.9
- Ìû×Ó: 13
- ÔÚÏß: 6.2Сʱ
- ³æºÅ: 1889453
- ×¢²á: 2012-07-12
- ÐÔ±ð: GG
6Â¥2014-12-07 21:57:52














»Ø¸´´ËÂ¥